This is entirely consistent with a recent study identifying IDH1 mutant glioblastomas to contain a significant non-contrast-enhancing component [8], whereby it is these garlands of microvascular proliferation which underlie the specific enhancements of contrast agents frequently observed in glioblastoma patients. This evidence concerns the gene IDH1 and glioblastoma.